Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Lasse Neukirch, Cyrielle Fougeroux, Anne-Marie Carola Andersson & Peter Johannes Holst. (2020) The potential of adenoviral vaccine vectors with altered antigen presentation capabilities. Expert Review of Vaccines 19:1, pages 25-41.
Read now
Read now
Karsten A. Pilones, Michal Hensler, Camille Daviaud, Jeffrey Kraynak, Jitka Fucikova, Lorenzo Galluzzi, Sandra Demaria & Silvia C. Formenti. (2020) Converging focal radiation and immunotherapy in a preclinical model of triple negative breast cancer: contribution of VISTA blockade. OncoImmunology 9:1.
Read now
Read now
Amanda J Oliver, Simon P Keam, Bianca von Scheidt, Damien J Zanker, Aaron J Harrison, Daniela GM Tantalo, Phillip K Darcy, Michael H Kershaw & Clare Y Slaney. (2020) Primary and metastatic breast tumors cross-talk to influence immunotherapy responses. OncoImmunology 9:1.
Read now
Read now
Jing Liu, Jake S. O’Donnell, Juming Yan, Jason Madore, Stacey Allen, Mark J. Smyth & Michele W. L. Teng. (2019) Timing of neoadjuvant immunotherapy in relation to surgery is crucial for outcome. OncoImmunology 8:5.
Read now
Read now
Jing Liu, Elisa A. Rozeman, Jake S. O’Donnell, Stacey Allen, Lorenzo Fanchi, Mark J. Smyth, Christian U. Blank & Michele W.L. Teng. (2019) Batf3+ DCs and type I IFN are critical for the efficacy of neoadjuvant cancer immunotherapy. OncoImmunology 8:2.
Read now
Read now
Articles from other publishers (32)
Isabella Skandorff, Jasmin Gille, Emeline Ragonnaud, Anne-Marie Andersson, Silke Schrödel, Christian Thirion, Ralf Wagner & Peter Johannes Holst. (2023) The Insertion of an Evolutionary Lost Four-Amino-Acid Cytoplasmic Tail Peptide into a Syncytin-1 Vaccine Increases T- and B-Cell Responses in Mice. Viruses 15:8, pages 1686.
Crossref
Crossref
Bei Li, Guohao Wang, Kai Miao, Aiping Zhang, Liangyu Sun, Xinwang Yu, Josh Haipeng Lei, Lisi Xie, Jie Yan, Wenxi Li, Chu-Xia Deng & Yunlu Dai. (2023) Fueling sentinel node via reshaping cytotoxic T lymphocytes with a flex-patch for post-operative immuno-adjuvant therapy. Nature Communications 14:1.
Crossref
Crossref
Joana Daradoumis, Emeline Ragonnaud, Isabella Skandorff, Karen Nørgaard Nielsen, Amaia Vergara Bermejo, Anne-Marie Andersson, Silke Schroedel, Christian Thirion, Lasse Neukirch & Peter Johannes Holst. (2023) An Endogenous Retrovirus Vaccine Encoding an Envelope with a Mutated Immunosuppressive Domain in Combination with Anti-PD1 Treatment Eradicates Established Tumours in Mice. Viruses 15:4, pages 926.
Crossref
Crossref
Joonbeom Bae, Longchao Liu, Casey Moore, Eric Hsu, Anli Zhang, Zhenhua Ren, Zhichen Sun, Xue Wang, Jiankun Zhu, Jiao Shen, Jian Qiao & Yang-Xin Fu. (2022) IL-2 delivery by engineered mesenchymal stem cells re-invigorates CD8+ T cells to overcome immunotherapy resistance in cancer. Nature Cell Biology 24:12, pages 1754-1765.
Crossref
Crossref
Ethan Shelkey, David Oommen, Elizabeth R. Stirling, David R. Soto-Pantoja, Katherine L. Cook, Yong Lu, Konstantinos I. Votanopoulos & Shay Soker. (2022) Immuno-reactive cancer organoid model to assess effects of the microbiome on cancer immunotherapy. Scientific Reports 12:1.
Crossref
Crossref
Yash Agarwal, Lauren E. Milling, Jason Y. H. Chang, Luciano Santollani, Allison Sheen, Emi A. Lutz, Anthony Tabet, Jordan Stinson, Kaiyuan Ni, Kristen A. Rodrigues, Tyson J. Moyer, Mariane B. Melo, Darrell J. Irvine & K. Dane Wittrup. (2022) Intratumourally injected alum-tethered cytokines elicit potent and safer local and systemic anticancer immunity. Nature Biomedical Engineering 6:2, pages 129-143.
Crossref
Crossref
Lauren E. Milling, Daniel Garafola, Yash Agarwal, Shengwei Wu, Ayush Thomas, Nathan Donahue, Josetta Adams, Nikki Thai, Heikyung Suh & Darrell J. Irvine. (2022) Neoadjuvant STING Activation, Extended Half-life IL2, and Checkpoint Blockade Promote Metastasis Clearance via Sustained NK-cell Activation. Cancer Immunology Research 10:1, pages 26-39.
Crossref
Crossref
Xuedan He, Shiqi Zhou, Breandan Quinn, Wei‐Chiao Huang, Dushyant Jahagirdar, Michael Vega, Joaquin Ortega, Mark D. Long, Fumito Ito, Scott I. Abrams & Jonathan F. Lovell. (2021)
Position‐Scanning Peptide Libraries as Particle Immunogens for Improving CD8
+
T‐Cell Responses
. Advanced Science 8:24, pages 2103023.
Crossref
Crossref
Marco Stringhini, Ilaria Spadafora, Marco Catalano, Jacqueline Mock, Philipp Probst, Roman Spörri & Dario Neri. (2021) Cancer therapy in mice using a pure population of CD8+ T cell specific to the AH1 tumor rejection antigen. Cancer Immunology, Immunotherapy 70:11, pages 3183-3197.
Crossref
Crossref
Mary Frances Wedekind, Katherine E. Miller, Chun-Yu Chen, Pin-Yi Wang, Brian J. Hutzen, Mark A. Currier, Brooke Nartker, Ryan D. Roberts, Louis Boon, Joe Conner, Stephanie LaHaye, Benjamin J. Kelly, David Gordon, Peter White, Elaine R. Mardis & Timothy P. Cripe. (2021) Endogenous retrovirus envelope as a tumor-associated immunotherapeutic target in murine osteosarcoma. iScience 24:7, pages 102759.
Crossref
Crossref
Roberta Zappasodi, Inna Serganova, Ivan J. Cohen, Masatomo Maeda, Masahiro Shindo, Yasin Senbabaoglu, McLane J. Watson, Avigdor Leftin, Rachana Maniyar, Svena Verma, Matthew Lubin, Myat Ko, Mayuresh M. Mane, Hong Zhong, Cailian Liu, Arnab Ghosh, Mohsen Abu-Akeel, Ellen Ackerstaff, Jason A. Koutcher, Ping-Chih Ho, Greg M. Delgoffe, Ronald Blasberg, Jedd D. Wolchok & Taha Merghoub. (2021) CTLA-4 blockade drives loss of Treg stability in glycolysis-low tumours. Nature 591:7851, pages 652-658.
Crossref
Crossref
Xuedan He, Shiqi Zhou, Wei-Chiao Huang, Amal Seffouh, Moustafa T. Mabrouk, M. Thomas Morgan, Joaquin Ortega, Scott I. Abrams & Jonathan F. Lovell. (2021)
A Potent Cancer Vaccine Adjuvant System for Particleization of Short, Synthetic CD8
+
T Cell Epitopes
. ACS Nano 15:3, pages 4357-4371.
Crossref
Crossref
Tania Løve Aaes & Peter Vandenabeele. (2020) The intrinsic immunogenic properties of cancer cell lines, immunogenic cell death, and how these influence host antitumor immune responses. Cell Death & Differentiation 28:3, pages 843-860.
Crossref
Crossref
Maria Hinterberger, Raphael Giessel, Giovanna Fiore, Fabienne Graebnitz, Barbara Bathke, Sonia Wennier, Paul Chaplin, Ignacio Melero, Mark Suter, Henning Lauterbach, Pedro Berraondo, Hubertus Hochrein & José Medina-Echeverz. (2021) Intratumoral virotherapy with 4-1BBL armed modified vaccinia Ankara eradicates solid tumors and promotes protective immune memory. Journal for ImmunoTherapy of Cancer 9:2, pages e001586.
Crossref
Crossref
Yael Raden, Inbar Shlomovitz & Motti Gerlic. (2021) Necroptotic extracellular vesicles – present and future. Seminars in Cell & Developmental Biology 109, pages 106-113.
Crossref
Crossref
Feihu Wang, Hao Su, Dongqing Xu, Wenbing Dai, Weijie Zhang, Zongyuan Wang, Caleb F. Anderson, Mengzhen Zheng, Richard Oh, Fengyi Wan & Honggang Cui. (2020) Tumour sensitization via the extended intratumoural release of a STING agonist and camptothecin from a self-assembled hydrogel. Nature Biomedical Engineering 4:11, pages 1090-1101.
Crossref
Crossref
Barbara Schrörs, Sebastian Boegel, Christian Albrecht, Thomas Bukur, Valesca Bukur, Christoph Holtsträter, Christoph Ritzel, Katja Manninen, Arbel D. Tadmor, Mathias Vormehr, Ugur Sahin & Martin Löwer. (2020) Multi-Omics Characterization of the 4T1 Murine Mammary Gland Tumor Model. Frontiers in Oncology 10.
Crossref
Crossref
Amaia Vergara Bermejo, Emeline Ragonnaud, Joana Daradoumis & Peter Holst. (2020) Cancer Associated Endogenous Retroviruses: Ideal Immune Targets for Adenovirus-Based Immunotherapy. International Journal of Molecular Sciences 21:14, pages 4843.
Crossref
Crossref
Emanuele Puca, Philipp Probst, Marco Stringhini, Patrizia Murer, Giovanni Pellegrini, Samuele Cazzamalli, Cornelia Hutmacher, Baptiste Gouyou, Sarah Wulhfard, Mattia Matasci, Alessandra Villa & Dario Neri. (2019)
The antibody‐based delivery of interleukin‐12 to solid tumors boosts NK and CD8
+
T cell activity and synergizes with immune checkpoint inhibitors
. International Journal of Cancer 146:9, pages 2518-2530.
Crossref
Crossref
Tania Løve Aaes, Hanne Verschuere, Agnieszka Kaczmarek, Liesbeth Heyndrickx, Bartosz Wiernicki, Iris Delrue, Bram De Craene, Joachim Taminau, Tinneke Delvaeye, Mathieu J. M. Bertrand, Wim Declercq, Geert Berx, Dmitri V. Krysko, Sandy Adjemian & Peter Vandenabeele. (2020) Immunodominant AH1 Antigen-Deficient Necroptotic, but Not Apoptotic, Murine Cancer Cells Induce Antitumor Protection. The Journal of Immunology 204:4, pages 775-787.
Crossref
Crossref
Jonathan G. Pol, Byram W. Bridle & Brian D. Lichty. 2020. Oncolytic Viruses. Oncolytic Viruses
191
211
.
Lasse Neukirch, Tea Kirkegaard Nielsen, Henriette Laursen, Joana Daradoumis, Christian Thirion & Peter Johannes Holst. (2019) Adenovirus based virus-like-vaccines targeting endogenous retroviruses can eliminate growing colorectal cancers in mice. Oncotarget 10:14, pages 1458-1472.
Crossref
Crossref
Philipp Probst, Marco Stringhini, Danilo Ritz, Tim Fugmann & Dario Neri. (2019) Antibody-based Delivery of TNF to the Tumor Neovasculature Potentiates the Therapeutic Activity of a Peptide Anticancer Vaccine. Clinical Cancer Research 25:2, pages 698-709.
Crossref
Crossref
Tyler W. Hulett, Shawn M. Jensen, Phillip A. Wilmarth, Ashok P. Reddy, Carmen Ballesteros-Merino, Michael E. Afentoulis, Christopher Dubay, Larry L. David & Bernard A. Fox. (2018) Coordinated responses to individual tumor antigens by IgG antibody and CD8+ T cells following cancer vaccination. Journal for ImmunoTherapy of Cancer 6:1.
Crossref
Crossref
Roberto De Luca & Dario Neri. (2018) Potentiation of PD-L1 blockade with a potency-matched dual cytokine–antibody fusion protein leads to cancer eradication in BALB/c-derived tumors but not in other mouse strains. Cancer Immunology, Immunotherapy 67:9, pages 1381-1391.
Crossref
Crossref
Xuedan He, Scott I. Abrams & Jonathan F. Lovell. (2018) Peptide Delivery Systems for Cancer Vaccines. Advanced Therapeutics 1:5, pages 1800060.
Crossref
Crossref
Weiwen DengVictor LiraThomas E. HudsonEdward E. LemmensWilliam G. HansonRuben FloresGonzalo BarajasGeorge E. KatibahAnthony L. DesbienPeter LauerMeredith L. LeongDaniel A. Portnoy & Thomas W. DubenskyJr.Jr.. (2018)
Recombinant
Listeria
promotes tumor rejection by CD8
+
T cell-dependent remodeling of the tumor microenvironment
. Proceedings of the National Academy of Sciences 115:32, pages 8179-8184.
Crossref
Crossref
Wantong Song, Limei Shen, Ying Wang, Qi Liu, Tyler J. Goodwin, Jingjing Li, Olekasandra Dorosheva, Tianzhou Liu, Rihe Liu & Leaf Huang. (2018) Synergistic and low adverse effect cancer immunotherapy by immunogenic chemotherapy and locally expressed PD-L1 trap. Nature Communications 9:1.
Crossref
Crossref
Kiyomi Shitaoka, Hiroshi Hamana, Hiroyuki Kishi, Yoshihiro Hayakawa, Eiji Kobayashi, Kenta Sukegawa, Xiuhong Piao, Fulian Lyu, Takuya Nagata, Daisuke Sugiyama, Hiroyoshi Nishikawa, Atsushi Tanemura, Ichiro Katayama, Mutsunori Murahashi, Yasushi Takamatsu, Kenzaburo Tani, Tatsuhiko Ozawa & Atsushi Muraguchi. (2018) Identification of Tumoricidal TCRs from Tumor-Infiltrating Lymphocytes by Single-Cell Analysis. Cancer Immunology Research 6:4, pages 378-388.
Crossref
Crossref
Philipp Probst, Janine Kopp, Annette Oxenius, Mario P. Colombo, Danilo Ritz, Tim Fugmann & Dario Neri. (2017) Sarcoma Eradication by Doxorubicin and Targeted TNF Relies upon CD8+ T-cell Recognition of a Retroviral Antigen. Cancer Research 77:13, pages 3644-3654.
Crossref
Crossref
Jing Liu, Stephen J. Blake, Michelle C.R. Yong, Heidi Harjunpää, Shin Foong Ngiow, Kazuyoshi Takeda, Arabella Young, Jake S. O'Donnell, Stacey Allen, Mark J. Smyth & Michele W.L. Teng. (2016) Improved Efficacy of Neoadjuvant Compared to Adjuvant Immunotherapy to Eradicate Metastatic Disease. Cancer Discovery 6:12, pages 1382-1399.
Crossref
Crossref
Marie T. Kim, Martin J. Richer, Brett P. Gross, Lyse A. Norian, Vladimir P. Badovinac & John T. Harty. (2015) Enhancing Dendritic Cell–based Immunotherapy with IL-2/Monoclonal Antibody Complexes for Control of Established Tumors. The Journal of Immunology 195:9, pages 4537-4544.
Crossref
Crossref